Ben Snedeker is a Partner and Co-Head of Public Equities at Catalio Capital Management, LP. He is primarily responsible for co-managing the Catalio Public Equities portfolio, investing across innovative healthcare companies in pharmaceuticals, biotech, medical devices, life science tools, diagnostics and data. He also serves as the Co-Head of Research with a focus on identifying opportunities for the research team to work together on investment opportunities across the life sciences capital structure. He serves on the firmwide Management Committee.
Prior to joining Catalio, Ben was Sector Head Therapeutics at HealthCor Management and PointState Capital and began his investing career as a therapeutics analyst and portfolio manager at D.E. Shaw & Co. on the long-short healthcare equities team. Ben was also an Associate Principal at McKinsey & Company in the Global Pharmaceuticals and Medical Products practice and a co-founder of McKinsey’s Philadelphia office.
Ben earned his B.S. degree in Chemistry from The Pennsylvania State University and his M.S. degree in Chemistry from Yale University.